Cost-effectiveness of biomarker-directed toripalimab plus chemotherapy for previously untreated extensive-stage small-cell lung-cancer in China - Shuo Kang; Shan Zhao; Xiaohui Wang; Zhenhua Pan (PLoS ONE, 2025)